Claim PIP for sleep apnea and DWP could give you up to £156 each week to help with costs More than 1,300 people across the UK are being supported through PIP for sleep apnea. Daily Record · Aug 10, 2022
Sleep apnea: KGMU Lucknow gets patent for device LUCKNOW: Patients suffering from sleep apnea will get better treatment at King George's Medical University(KGMU) as the prosthodontics department has got a patent for a device it made for accurately measuring the gap between upper and lower jaw. The Times of India · Jul 26, 2022
Bumrungrad rests easy with sleep clinic Bumrungrad International Hospital has announced the opening of its Comprehensive Sleep Clinic to address sleep-related conditions. Bangkok Post · Jul 10, 2022
What SVB Says On Axsome's Strategy Review On Sunosi For Sleeping Disorder Axsome Therapeutics Inc (NASDAQ: AXSM) held an investor event to review its strategy with Sunosi, which is indicated for excessive daytime sleepiness (EDS) in narcolepsy and obstructive sleep apnea (OSA). SVB Leerink says its view on Sunosi has not changed. Benzinga · Jun 29, 2022
ResMed Strengthens Its Out-Of-Hospital Software Solutions Position With Latest Acquisition - Read How ResMed Inc (NYSE:RMD) has agreed to acquire privately-held MEDIFOX DAN, a Germany-based provider of out-of-hospital software solutions, from Hg, a software and services investor. MEDIFOX DAN's clinical, financial, and operational solutions are similar to ResMed's U.S. SaaS brands, MatrixCare and Brightree. MEDIFOX DAN's German customer base is complementary to the customers of ResMed's U.S.-based… Benzinga · Jun 14, 2022
Kansas man says he got lung cancer from CPAP sleep apnea machine. He’s suing KANSAS CITY, Mo. — A Johnson County, Kansas, man blames his sleep apnea machine for giving him lung cancer and is suing the manufacturer, which last year recalled the machine and several other breathing-aid devices. Tribune News Service · Jun 9, 2022
Incannex Reveals Clinical Trial Results On Dronabinol-Based Drug For Obstructive Sleep Apnea Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL), a clinical-stage pharmaceutical company developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for unmet medical needs, has completed an analysis of data from the Phase 2 proof-of-concept clinical trial invest Benzinga · Jun 3, 2022